Products for Research Use Only

Rasagiline

CAT: 0804-HY-14605A-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-14605A-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Rasagiline (R-AGN1135) is a highly potent selective irreversible mitochondrial monoamine oxidase (MAO) inhibitor with IC50s of 4.43 nM and 412 nM for rat brain MAO B and A activity, respectively[1]. Rasagiline is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
CAS Number
136236-51-6
Product Name Alternative
(R) -AGN1135; TVP1012
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Monoamine Oxidase
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/rasagiline.html
Concentration
10mM
Purity
99.88
Solubility
DMSO : 100 mg/mL (ultrasonic) |H2O : ≥ 5.88 mg/mL
Smiles
C#CCN[C@H]1C2=CC=CC=C2CC1
Molecular Formula
C12H13N
Molecular Weight
171.24
Precautions
H302, H315, H319, H335
References & Citations
[1]M B Youdim, et al. Rasagiline [N-propargyl-1R (+) -aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B. Br J Pharmacol. 2001 Jan;132 (2) :500-6.|[2]Shawna Tazik, et al. Comparative neuroprotective effects of Rasagiline and aminoindan with selegiline on dexamethasone-induced brain cell apoptosis. Neurotox Res. 2009 Apr;15 (3) :284-90.|[3]Nadia Stefanova, et al. Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Exp Neurol. 2008 Apr;210 (2) :421-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
MAO-A; MAO-B
Citation 01
Bioorg Chem. 2023 Sep:138:106654.|Eur J Med Chem. 2023 Jul 5:255:115417.|Front Cell Neurosci. 2018 Sep 11:12:309.|Behav Brain Res. 2024 Feb 29:459:114787.|Eur J Med Chem. 2024 Dec 5:279:116842.|J Neuroinflammation. 2025 Apr 29;22 (1) :125.|Oncotarget. 2018 Jan 30;9 (15) :12137-12153.